Getting AstraZeneca vaccine still ‘doable’ even with company pullout from trial

  • 📰 inquirerdotnet
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 86%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

At least 2.6 million COVID-19 vaccines from AstraZeneca may still be available in the Philippines next year even though the drug company had already withdrawn its application to do clinical trials in the country. | roycanivel_inq

Half of the donations will be for government medical front-liners and the other half, for employees in the private sector, including both regular and contractual workers.

Concepcion earlier said that due to overwhelming demand, AstraZeneca was accepting more orders from the Philippine private sector. “We are happy to announce that with enough support, and of course, demand coming from the private sector, the second [batch] is now already in the works. The signing we did few weeks ago made into several headlines and we received several inquiries from the private sector asking for more allocation, hence, a request to AstraZeneca to hopefully allow us to have a second batch,” he said in a statement.

Concepcion, however, did not respond to requests for comment. He did not reply when asked how other private businesses could donate to the initiative. INQFor more information on COVID-19, call the DOH Hotline: 86517800 local 1149/1150. The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro current account #007960018860 or donate through PayMaya using this

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 3. in JP

日本 最新ニュース, 日本 見出し